A standing rule for this whole program, stated once and applied on every page below: these capabilities exist to prevent diversion, identity theft, misidentification and preventable overdose, and to give clinicians and agencies the clinical context that count-based analysis lacks. They do not exist to police people who are in pain. Where a capability could be turned to that use, the page says so.

Getting the medication to the person

• Pharmaceutical delivery partnerships — closing therapy gaps for people without reliable transportation, and removing the informal courier who is a diversion point.
• Safe storage and rescue medication — naloxone in the home and a lockable place to keep controlled medication.

Knowing who is receiving it

• Biometric cross-validation — palm-vein or 3D facial confirmation at the point of transfer.
• DNALock — a buccal-swab identity anchor for the specimen chain.
• Custodial toxicology — chain-of-custody collection so a result can never be attributed to the wrong person.

Understanding the clinical picture

• ProviderSynch — a pull API that returns a health-history summary when a prescription is transmitted.
• EMR and LIS integration — diagnosis coding, laboratory results, chronic care management and remote therapeutic monitoring (RTM) in one view.
• Metabolic determination — identifying pharmacokinetic outliers instead of marginalizing them.
• MedimetRx psychometrics — validated behavioral health screening, scored against normative data and against the person’s own history.
• Remote patient monitoring — consented between-visit signal, with early identification of depression and suicidality.

Assessing risk honestly

• Risk assessment — medical, social and family history, per the federal Task Force recommendation.
• Social determinants verification — confirming circumstances so that support is matched to actual need.
• AI integrated rule discovery — the simplest model that explains the data, deliberately avoiding black-box complexification.

Watching the supply, not the patient

• Drug-supply signal analysis — what substances are circulating in a region, under what street names.
• Population-based emerging threat analysis — detecting a change in the local supply early enough to warn people.
• Integrated real-time overdose registry — a shared, current picture of overdose events across an agency’s jurisdiction.